Single-Rod Gestodene Implant
- User: Female
- Hormonal: Hormonal
-
Delivery type:
- Subdermal
-
Intended Duration:
- Long-Acting
- Development Stage: Phase I
- Developer(s)/researcher(s): Shanghai Institute of Planned Parenthood Research
Details
- API: Gestodene
- Target: Progesterone Receptor
-
Mechanism of Action:
- Ovulation Inhibition
- Cervical Mucus Changes
- Endometrial Changes
- Inactive Materials: Polymer - Nonspecific
- Regimen: 1 Insertion/5 Years
- MPT: Not Potential MPT
- Promising Attributes: Not Established - Limited Public Information
Product Status
No Indication of Development after 2007
History
2007: SIPPR releases findings from pre-clinical and early-stage clinical evaluation of a single-rod gestodene implant which indicate potential viability as a long-acting contraceptive